Research
LIMS researchers are primarily concerned with understanding the fundamental processes in cell and molecular science and developing their potential applications in medicine, nanotechnology and biotechnology.
While the development of specialised disease treatments is always a priority for researchers, in the face of an ageing population, the discovery and development of vaccines, therapeutic and diagnostic products that will keep an ageing population healthy is of great importance.
LIMS will support, expand and extend the research work of La Trobe’s School of Molecular Sciences; ultimately positioning La Trobe University as the biotechnology hub of the northern Melbourne science precinct.
Recent highlights
Findings released in early 2011 by Excellence in Research for Australia (a division of the Australia Research Council) ranked La Trobe as the leading university in Australia for research in Biochemistry and Cell Biology, both of which are housed within LIMS.
La Trobe’s research in these fields was rated as ‘well above world standard’, the only university in Australia to gain such a rating. Overall, La Trobe ranks among Australia’s top eight universities in the Biological Sciences.
La Trobe’s ranking was based on the quantity and quality of it publications in these areas and the degree to which these publications were cited by other studies.
Research funding
Researchers at LIMS have a strong record of successfully attracting competitive grant funding. The institute currently generates A$12 million in research income; however, this figure is expected to increase to A$15 million annually once the new LIMS complex is completed.
Current funding sources include the Australian Research Council, the National Health and Medical Research Council, and grants from international sources.